ArticleEuropean journal of nuclear medicine and molecular imaging2021

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

Y Touchefeu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.